MONTREAL, Oct. 22 /PRNewswire/ -- Global Vision, the leader in automated proofreading solutions for the pharmaceutical industry announced today that 15 of the top 20 pharmaceutical companies have selected Global Vision to help them reduce the risk of textual and artwork errors from occurring in their packaging process. The integration of automated proofreading technology has resulted in a reduction of quality issues and costs, along with speeding up product launches.
Debi Schimpf, Associate Director at Wyeth comments "Global Vision has helped us implement better methods for detecting errors before they become costly. They're extremely knowledgeable when it comes to securing the artwork packaging workflow. Over the last 10 years of working with Global Vision, we have realized significant benefits and financial savings."
In the pharmaceutical manufacturing environment, there are thousands of packaging components being produced in a multitude of languages each year. Keeping track of the accuracy of these materials is a complex and challenging undertaking. Global Vision's technology is becoming a standard way for companies to ensure that their products reach the shelves without labeling errors.
"These companies are turning to us because we can offer them a safer and simpler way to work. Our customers need to feel confident in their approval and change control process. We give them peace of mind, along with the added benefits of decreased approval times and significant cost savings," says President Reuben Malz.
Global Vision is committed to providing solutions to ensure that all aspects of the packaging process are accurate. Global Vision has recently integrated Braille inspection capabilities into all its solutions in compliance with the recent EMEA regulations that require Braille on labels and cartons.
All systems meet EMEA and FDA 21 CFR Part 11 requirements.
About Global Vision
Global Vision provides automa
|SOURCE Global Vision, Inc.|
Copyright©2008 PR Newswire.
All rights reserved